LL-37 vs GHK-Cu
Side-by-side comparison of LL-37, GHK-Cu — mechanism, dosing, half-life, side effects, and research status.
| Attribute | LL-37 LL-37 (Human Cathelicidin Antimicrobial Peptide) Recovery | GHK-Cu Glycyl-L-Histidyl-L-Lysine Copper Complex Recovery |
|---|---|---|
| Basics | ||
| Molecular type | Human Cathelicidin | Copper-Binding Tripeptide |
| Amino acids | 37 | 3 |
| Molecular weight | 4,493.3 Da | 340.4 Da |
| Half-life | Short (hours) | Short (minutes to hours) |
| Route(s) | Subcutaneous, Topical, Intranasal | Subcutaneous, Topical (skin), IV (research) |
| Mechanism & Research | ||
| Primary mechanism | LL-37 disrupts microbial membranes through electrostatic interaction — its cationic amphipathic helical structure inserts into negatively charged bacterial membranes, causing lethal membrane permeabilisation. This mechan… | GHK-Cu forms a stable complex with copper(II), which is essential for its biological activity. The copper complex activates collagenase and other metalloproteinases that remodel damaged extracellular matrix while simulta… |
| Research status | Research Compound | Research Compound |
| Evidence summary | LL-37 has been studied extensively for wound healing, respiratory infections (including COVID-19 lung immunity), and more recently for senolytic applications. Its broad antimicrobial and immunomodulatory profile makes it… | GHK-Cu is one of the most thoroughly researched cosmetic and wound-healing peptides. Topical GHK-Cu is commercially used in skincare. Deeper systemic applications (anti-aging, neuroprotection, systemic collagen support) … |
| Protocol & Dosing | ||
| Typical dose | 1–5 mg per injection or topical application | 1–2 mg/day (SC); topical as needed |
| Frequency | Daily | Daily |
| Duration | 4–8 weeks | 8–12 weeks |
| Timing | Any time | Any time of day |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Not Prohibited | Not Prohibited |
| Deeper reading | ||
| Related peptides | BPC-157, GHK-Cu, KPV | BPC-157, Epithalon, LL-37 |
| Full profile | Read full LL-37 profile → | Read full GHK-Cu profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.